Antonio Trejo Diaz

Antonio Trejo Diaz has extensive experience in regulatory affairs, particularly in the pharmaceutical and healthcare industries. Antonio has held various leadership positions in different companies, including Brainstorm Cell Therapeutics, Takeda, Saol Therapeutics, Elekta, Teva Pharmaceuticals, Hospira, Bayer, Wyeth Consumer Healthcare, Baxter Healthcare, and Signa SA de CV.

In their most recent role as the Vice President of Regulatory Affairs at Brainstorm Cell Therapeutics, they lead the Regulatory Affairs organization and is responsible for the development and registration of cell therapy and exosome products on the CNS. Antonio also interacts with the FDA and other health authorities and implements the company's global regulatory and compliance strategy.

Prior to that, as the Head of Global Regulatory Compliance at Takeda, they fostered a culture of compliance within Regulatory Affairs and provided global oversight for the development, communication, implementation, and execution of the Regulatory Compliance culture and strategy.

At Saol Therapeutics, they served as the Head of Regulatory Affairs and led the global regulatory affairs organization supporting the registration and commercialization of the Rare Disease and Neuroscience portfolio and pipeline.

At Elekta, they were the Regulatory Affairs Director Americas, where they developed and executed the regulatory strategy for the registration of new radiotherapy medical device products and provided strategic leadership for the existing portfolio.

In their role at Teva Pharmaceuticals, Antonio led the Regulatory Affairs organization in the Latin America, APAC, and other countries, overseeing new product registrations, maintenance of the existing portfolio, and ensuring regulatory compliance.

Antonio also held positions at Hospira, Bayer, Wyeth Consumer Healthcare, Baxter Healthcare, and Signa SA de CV, where they contributed to various aspects of regulatory affairs, including strategy development, portfolio maintenance, regulatory conformance, and compliance.

Overall, Antonio Trejo Diaz has a strong background in regulatory affairs and extensive experience in leading regulatory affairs teams, developing and executing regulatory strategies, ensuring compliance with regulations, and supporting the registration and commercialization of various healthcare products.

Antonio Trejo Diaz has a diverse education history. Antonio first attended King's College London from 1998 to 1999, where they earned a Master of Science (MSc) degree in Pharmaceutical Technology. Following this, they pursued their Bachelor of Science (BSc) degree in Pharmaceutical Chemistry from Universidad Autónoma Metropolitana, completing their studies from 1992 to 1996.

In 2003, Antonio enrolled at Universidad Iberoamericana, Ciudad de México, where they obtained a Master of Business Administration (MBA) degree in Administration. Antonio dedicated three years of study to this program, concluding their studies in 2006. Antonio later pursued their passion for executive education by attending the Executive Development Program at Northwestern University - Kellogg School of Management in 2016. This program focused on Administration and General Business Management.

Antonio's dedication to furthering their education is evident through their additional certifications. Antonio obtained the RAC certification, although the details regarding the institution, month, and year obtained are not available.

Additionally, Antonio engaged in further learning opportunities in business administration and management. In 2016, they participated in the Executive Management program offered by Kellogg Executive Education, which covered topics in Business Administration and Management, expanding their knowledge in this field.

Overall, Antonio Trejo Diaz possesses a comprehensive educational background, with degrees in Pharmaceutical Technology, Pharmaceutical Chemistry, and an MBA in Administration. Antonio has also engaged in executive education and obtained additional certifications to enhance their expertise in the field of business administration and management.